Combination antihypertensive therapy.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000661:Amphetamine / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001581:Benzothiadiazines; D003000:Clonidine / Q000627:therapeutic use; D003647:Debrisoquin / Q000627:therapeutic use; D004232:Diuretics; D004338:Drug Combinations; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D008750:Methyldopa / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal; D011189:Potassium Chloride / Q000627:therapeutic use; D011926:Rauwolfia / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use; D014223:Triamterene / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D004338:Drug Combinations; D008996:Monoamine Oxidase Inhibitors; D046948:Secologanin Tryptamine Alkaloids; D049993:Sodium Chloride Symporter Inhibitors; D013566:Sympathomimetics; D006830:Hydralazine; D013148:Spironolactone; D008750:Methyldopa; D011189:Potassium Chloride; D012110:Reserpine; D000661:Amphetamine; D010653:Phenylbutazone; D003000:Clonidine; D014223:Triamterene; D003647:Debrisoquin; D006145:Guanethidine